Close Menu

FDA

In its annual report, Exiqon also indicated that it would eventually seek US Food and Drug Administration approval for its miRNA diagnostics so that they could be made available to a broader range of laboratories and pathologists.

The FDA has confirmed to DxS that its TheraScreen KRAS test is a Class III device. The company is in the process of submitting its premarket approval application to the agency.

The data presented last week at the Molecular Medicine Tri-Conference showed that the investigational test detected "dramatically different" miRNA expression patterns in the blood of cancer patients compared to those who were cancer-free.

Patent Reform Act reintroduced; FDA clears UF-developed wound care tech; GSK inks ophthalmology research pact with University College London, and more ...

Qiagen said that PreAnalytix's PAXgene system is now the only collection, stabilization, and purification method — either automated or manual — available in the US for IVD use.

In Print: Mar 3, 2009

Premium

Microarray-Related Papers of Note, February 2009

Georgia Biotech Tort-Shield Bill, Michigan 'Cluster of Innovation,' Maryland Nanobiotechnology Grants, North Carolina Biotechnology Center, Solano Economic Development Corp., Hong Kong Stimulus Package

The integration of ADMETRx's ADME evaluation and CeeTox's toxicity screening during drug discovery and lead optimization will help pharmaceutical and biotech companies efficiently improve their drug discovery decision making capabilities, a CeeTox official told CBA News.

The agency will use the mass spec system in its ARS service to develop screens for drugs in livestock and poultry.

Mari Baker is leaving Navigenics, Andrew von Eschenbach has joined a consulting firm, Jay Flatley takes a seat on Helixis' board, and more.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.